Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
01 2020
Historique:
received: 06 06 2019
accepted: 22 11 2019
entrez: 18 2 2020
pubmed: 18 2 2020
medline: 20 11 2020
Statut: epublish

Résumé

To uncover the genetic basis of anthracycline-induced cardiotoxicity (AIC), we recently established a genetic suppressor screening strategy in zebrafish. Here, we report the molecular and cellular nature of

Identifiants

pubmed: 32064346
doi: 10.1126/sciadv.aay2939
pii: aay2939
pmc: PMC6989136
doi:

Substances chimiques

Cardiotonic Agents 0
RXRA protein, human 0
Retinoid X Receptor alpha 0
Zonula Occludens-1 Protein 0
Bexarotene A61RXM4375
Isotretinoin EH28UP18IF

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eaay2939

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL081753
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002379
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL107304
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL111437
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM063904
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG006431
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002377
Pays : United States

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Références

Biol Open. 2016 Oct 15;5(10):1362-1370
pubmed: 27543060
JCI Insight. 2016 Sep 8;1(14):
pubmed: 27642634
J Am Coll Cardiol. 2017 Jul 11;70(2):163-164
pubmed: 28683963
Development. 2011 Jul;138(14):2895-902
pubmed: 21653610
Clin Cancer Res. 2017 Jan 1;23(1):43-51
pubmed: 27993963
Dis Model Mech. 2017 Jan 1;10(1):63-76
pubmed: 28067629
Cardiology. 2010;115(2):155-62
pubmed: 20016174
Nat Methods. 2011 Jun;8(6):506-15
pubmed: 21552255
Development. 1998 May;125(10):1951-6
pubmed: 9550727
Genes Dev. 1994 May 1;8(9):1007-18
pubmed: 7926783
Circ Res. 2002 Apr 19;90(7):764-9
pubmed: 11964368
Oncologist. 2008 Apr;13(4):445-50
pubmed: 18448560
Cardiovasc Res. 2016 May 1;110(1):85-95
pubmed: 26862121
Biogerontology. 2014 Feb;15(1):47-64
pubmed: 24243065
Ann Oncol. 2014 Jan;25(1):206-10
pubmed: 24285015
Circ Res. 2011 Sep 2;109(6):658-69
pubmed: 21757652
J Mol Cell Cardiol. 2013 Apr;57:106-18
pubmed: 23395853
Int J Cardiol. 2016 Feb 15;205:99-110
pubmed: 26730840
Nat Med. 2012 Nov;18(11):1639-42
pubmed: 23104132
Genes Dev. 2004 Jun 1;18(11):1345-58
pubmed: 15175265
J Clin Invest. 2000 Feb;105(3):387-94
pubmed: 10675365
Biochim Biophys Acta. 2008 Mar;1778(3):794-809
pubmed: 17961505
PLoS Genet. 2013;9(8):e1003689
pubmed: 23990796
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18455-60
pubmed: 16352730
Nat Rev Drug Discov. 2007 Oct;6(10):793-810
pubmed: 17906642
PLoS Genet. 2018 Nov 14;14(11):e1007754
pubmed: 30427827
Exp Cell Res. 2001 Feb 1;263(1):163-72
pubmed: 11161715
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13144-13149
pubmed: 27799559
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6115-20
pubmed: 23530216
Development. 2003 Dec;130(26):6465-74
pubmed: 14627725
Pharmacol Rev. 2004 Jun;56(2):185-229
pubmed: 15169927
J Neurosci. 2013 Jan 23;33(4):1660-71
pubmed: 23345238
Nat Genet. 2015 Sep;47(9):1079-84
pubmed: 26237429
Dev Cell. 2011 Mar 15;20(3):397-404
pubmed: 21397850
Pharmacogenet Genomics. 2017 Oct;27(10):378-385
pubmed: 28763429
Nat Commun. 2017 May 09;8:15281
pubmed: 28485381
Sci Transl Med. 2014 Dec 10;6(266):266ra170
pubmed: 25504881
Cell. 2014 Mar 27;157(1):255-66
pubmed: 24679540
Development. 1998 May;125(10):1943-9
pubmed: 9550726
Dis Model Mech. 2018 Sep 10;11(9):
pubmed: 30012855
Nat Med. 2016 May;22(5):547-56
pubmed: 27089514
J Cell Physiol. 2011 May;226(5):1292-307
pubmed: 20945395
Circulation. 2002 Jul 30;106(5):606-12
pubmed: 12147544
Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7391-5
pubmed: 7638203
Cardiovasc Drugs Ther. 2017 Feb;31(1):63-75
pubmed: 28185035

Auteurs

Xiao Ma (X)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, USA.
Mayo Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA.

Ping Zhu (P)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Yonghe Ding (Y)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Hong Zhang (H)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Clinical Center for Gene Diagnosis and Therapy, The Second Xiangya Hospital of Central South University, Changsha, China.

Qi Qiu (Q)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Institute of Clinical Pharmacology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Alexey V Dvornikov (AV)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Zheng Wang (Z)

Department of Medicine, Mayo Clinic, Rochester, MN, USA.

Maengjo Kim (M)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Yong Wang (Y)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Institute of Life Science, Beijing University of Chinese Medicine, Beijing, China.

Matthew Lowerison (M)

Department of Urology, Mayo Clinic, Rochester, MN, USA.

Yue Yu (Y)

Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

Nadine Norton (N)

Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.

Joerg Herrmann (J)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Stephen C Ekker (SC)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, USA.
Mayo Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA.

Tzung K Hsiai (TK)

School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

Xueying Lin (X)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Xiaolei Xu (X)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, USA.
Mayo Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH